Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


11.12.2017

1 Adv Clin Exp Med
1 Am J Cancer Res
1 BJU Int
1 BMC Complement Altern Med
1 BMC Res Notes
1 BMC Urol
1 Cancer
1 Curr Opin Urol
1 Eur J Surg Oncol
1 Eur Urol
1 Exp Cell Res
1 Indian J Surg Oncol
1 Int Braz J Urol
1 Int J Biol Sci
1 Int J Urol
1 J Urol
1 Med Oncol
1 Medicine (Baltimore)
1 Mutat Res
1 Nat Rev Urol
2 Onco Targets Ther
1 Oncol Rep
4 Oncotarget
1 PLoS One
1 Radiology
1 Turk J Urol
1 Urol Int
2 Urology
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Adv Clin Exp Med

  1. SZYMANSKA B, Pawlik KJ, Sawicka E, Dembowski J, et al
    Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins.
    Adv Clin Exp Med. 2017;26:1069-1075.
    PubMed     Text format     Abstract available


    Am J Cancer Res

  2. YANG D, Du G, Xu A, Xi X, et al
    Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.
    Am J Cancer Res. 2017;7:2209-2219.
    PubMed     Text format     Abstract available


    BJU Int

  3. MAURICE MJ, Kaouk JH
    Robotic radical perineal cystectomy and extended pelvic lymphadenectomy: initial investigation using a purpose-built single-port robotic system.
    BJU Int. 2017;120:881-884.
    PubMed     Text format     Abstract available


    BMC Complement Altern Med

  4. CHIU SC, Chiu TL, Huang SY, Chang SF, et al
    Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells.
    BMC Complement Altern Med. 2017;17:523.
    PubMed     Text format     Abstract available


    BMC Res Notes

  5. BONFILL X, Martinez-Zapata MJ, Vernooij RWM, Sanchez MJ, et al
    Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study.
    BMC Res Notes. 2017;10:708.
    PubMed     Text format     Abstract available


    BMC Urol

  6. MOHAMMED A, Arastu Z
    Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer.
    BMC Urol. 2017;17:114.
    PubMed     Text format     Abstract available


    Cancer

  7. WELTY CJ, Sanford TH, Wright JL, Carroll PR, et al
    The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
    Cancer. 2017;123:4574-4582.
    PubMed     Text format     Abstract available


    Curr Opin Urol

  8. FANKHAUSER CD, Mostafid H
    Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.
    Curr Opin Urol. 2018;28:88-92.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  9. MALTE R, Kluth LA, Kaushik D, Boorjian SA, et al
    Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study.
    Eur J Surg Oncol. 2017;43:2193-2199.
    PubMed     Text format     Abstract available


    Eur Urol

  10. ODDENS JR, de Reijke TM
    The Current State of Predicting Response on Bacillus Calmette-Guerin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action.
    Eur Urol. 2017 Nov 30. pii: S0302-2838(17)31006.
    PubMed     Text format    


    Exp Cell Res

  11. D'ALOIA A, Berruti G, Costa B, Schiller C, et al
    RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30639.
    PubMed     Text format     Abstract available


    Indian J Surg Oncol

  12. PUNEET A, Balagopal N, Ginil K, Georgie M, et al
    Correlation of Transabdominal Ultrasonography and Cystoscopy in Follow-up of Patients with Non-muscle Invasive Bladder Cancer.
    Indian J Surg Oncol. 2017;8:548-553.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  13. KULKARNI JN, Agarwal H
    Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study.
    Int Braz J Urol. 2017;43.
    PubMed     Text format     Abstract available


    Int J Biol Sci

  14. WONG JPC, Wei R, Lyu P, Tong OLH, et al
    Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.
    Int J Biol Sci. 2017;13:1373-1386.
    PubMed     Text format     Abstract available


    Int J Urol

  15. OHNO Y
    Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Dec 7. doi: 10.1111/iju.13506.
    PubMed     Text format    


    J Urol

  16. DANESHMAND S, Patel S, Lotan Y, Pohar K, et al
    Efficacy and Safety of Blue Light Flexible Cystoscopy With Hexaminolevulinate (Hal) in the Surveillance of Bladder Cancer: A Phase Iii, Comparative, Multi-Center Study.
    J Urol. 2017 Dec 1. pii: S0022-5347(17)78004-4. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Med Oncol

  17. PASSOS GR, Camargo JA, Ferrari KL, Saad MJA, et al
    Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment.
    Med Oncol. 2017;35:3.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  18. TAKIZAWA T, Kojima M, Suzuki S, Osada T, et al
    New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.
    Medicine (Baltimore). 2017;96:e8757.
    PubMed     Text format     Abstract available


    Mutat Res

  19. ZHOU N, Yuan Y, Long X, Wu C, et al
    Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.
    Mutat Res. 2017;806:27-30.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  20. THOMA C
    Bladder cancer: Genomics of noninvasive disease.
    Nat Rev Urol. 2017 Dec 5. pii: nrurol.2017.207. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Onco Targets Ther

  21. CUI J, Chen S, Bo Q, Wang S, et al
    Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ.
    Onco Targets Ther. 2017;10:5541-5550.
    PubMed     Text format     Abstract available

  22. ZHAO F, Ge YZ, Zhou LH, Xu LW, et al
    Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis.
    Onco Targets Ther. 2017;10:5551-5559.
    PubMed     Text format     Abstract available


    Oncol Rep

  23. TAKAMURA T, Horinaka M, Yasuda S, Toriyama S, et al
    FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
    Oncol Rep. 2017 Dec 1. doi: 10.3892/or.2017.6127.
    PubMed     Text format     Abstract available


    Oncotarget

  24. HU Y, Deng C, Zhang H, Zhang J, et al
    Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/beta-catenin signaling pathway in bladder cancer.
    Oncotarget. 2017;8:94554-94568.
    PubMed     Text format     Abstract available

  25. ZHANG Q, Wang C, Miao S, Li C, et al
    Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.
    Oncotarget. 2017;8:93969-93983.
    PubMed     Text format     Abstract available

  26. AZEVEDO R, Peixoto A, Gaiteiro C, Fernandes E, et al
    Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
    Oncotarget. 2017;8:91734-91764.
    PubMed     Text format     Abstract available

  27. SILVERS CR, Miyamoto H, Messing EM, Netto GJ, et al
    Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.
    Oncotarget. 2017;8:91199-91208.
    PubMed     Text format     Abstract available


    PLoS One

  28. BOGNAR Z, Fekete K, Antus C, Hocsak E, et al
    Desethylamiodarone-A metabolite of amiodarone-Induces apoptosis on T24 human bladder cancer cells via multiple pathways.
    PLoS One. 2017;12:e0189470.
    PubMed     Text format     Abstract available


    Radiology

  29. HUANG L, Kong Q, Liu Z, Wang J, et al
    The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis.
    Radiology. 2017 Dec 4:171028. doi: 10.1148/radiol.2017171028.
    PubMed     Text format     Abstract available


    Turk J Urol

  30. SANLI O, Lotan Y
    Alternative therapies in patients with non-muscle invasive bladder cancer.
    Turk J Urol. 2017;43:414-424.
    PubMed     Text format     Abstract available


    Urol Int

  31. ZATTONI F, Palumbo V, Giannarini G, Crestani A, et al
    Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer.
    Urol Int. 2017 Dec 7. pii: 000478990. doi: 10.1159/000478990.
    PubMed     Text format     Abstract available


    Urology

  32. XU H, Ma J, Chen Z, Yang J, et al
    Safety and Efficacy of en Bloc Transurethral Resection with 1.9Mum Vela Laser for Treatment of Non-Muscle-Invasive Bladder Cancer.
    Urology. 2017 Nov 30. pii: S0090-4295(17)31231.
    PubMed     Text format     Abstract available

  33. SHINDO T, Shimizu T, Nojima M, Niinuma T, et al
    Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: a Two-Center Prospective Study.
    Urology. 2017 Nov 28. pii: S0090-4295(17)31223.
    PubMed     Text format     Abstract available


    World J Urol

  34. KRIEGMAIR MC, Honeck P, Theuring M, Bolenz C, et al
    Wide-field autofluorescence-guided TUR-B for the detection of bladder cancer: a pilot study.
    World J Urol. 2017 Dec 6. pii: 10.1007/s00345-017-2147.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: